Although the specific role of endothelial p53 in the development of diabetic cardiomyopathy remains unknown, endothelial p53 deletion has been demonstrated to inhibit mesenchymal differentiation, and to prevent cardiac fibrosis and heart failure induced by pressure overload 82. This evidence concerns the gene TP53 and diabetic cardiomyopathy.